Literature DB >> 2782915

[Basic and clinical evaluation of an immunoradiometric competitive inhibition assay for sialyl Tn antigen: (1). Evaluation of assay conditions and normal values. STN Study Group].

H Imura, T Mori, H Ohkura, M Ishii, H Ariyoshi, J Endo, M Kitao, I Takeda, H Kobayashi, M Inoue.   

Abstract

An immunoradiometric competitive inhibition assay of the serum levels of the sialyl Tn antigen using "STN Otsuka" kits is described. The assay required only duplicate 50-microliters samples, and the concentration of sialyl Tn antigen in serum was determined by reference to a standard curve ranging from 0 to 400 arbitrary units/ml. The intra-and inter-assay reproducibilities were largely satisfactory. The serum levels of the antigen in normal individuals were not affected by ABO and Lewis blood type status of the tested individuals. Normal values were 25.5 +/- 9.8 in male, and 21.3 +/- 8.0 in female, and the difference was statistically significant at p less than 0.001. The serum level of the antigen was not affected by menstrual cycle or pregnancy in female, whereas the level of other tumor markers such as CA 125 was highly variable depending upon these conditions.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2782915

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  3 in total

1.  Jellyfish mucin may have potential disease-modifying effects on osteoarthritis.

Authors:  Naoshi Ohta; Masato Sato; Kiminori Ushida; Mami Kokubo; Takayuki Baba; Kayoko Taniguchi; Makoto Urai; Koji Kihira; Joji Mochida
Journal:  BMC Biotechnol       Date:  2009-12-08       Impact factor: 2.563

2.  Combined evaluation of preoperative serum sialyl-Tn antigen and carcinoembryonic antigen levels is prognostic for gastric cancer patients.

Authors:  I Takahashi; Y Maehara; T Kusumoto; S Kohnoe; Y Kakeji; H Baba; K Sugimachi
Journal:  Br J Cancer       Date:  1994-01       Impact factor: 7.640

3.  Correlation between sialyl Tn antigen and lymphatic metastasis in patients with Borrmann type IV gastric carcinoma.

Authors:  Y Kakeji; Y Maehara; M Morita; A Matsukuma; M Furusawa; I Takahashi; T Kusumoto; S Ohno; K Sugimachi
Journal:  Br J Cancer       Date:  1995-01       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.